Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period of September 4, 2018. The registrant is a foreign private issuer based in Israel. The filing serves to incorporate a press release regarding interim results from a post-CE approval study of the Company's C-Scan® System Version 3.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes
The material change disclosed is the announcement of promising interim results from an ongoing post-CE approval study for the C-Scan® System Version 3. No comparative financial data or prior period changes are included in this document.
Guidance, Outlook, and Risks
Management commentary is limited to the attached press release (Exhibit 99.1) highlighting the positive interim study results. The filing does not contain specific forward-looking guidance, risk factors, contingencies, or unusual items beyond the study announcement.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for specific clinical data points.
- Confirm the regulatory status and timeline for the C-Scan® System Version 3 post-CE approval study.
- Review subsequent filings for any financial impact resulting from the study results.